- Anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine and associated factors in Japanese hemodialysis patients
-
Hirai K, Shimotashiro M, Okumura T, Ookawara S, Morishita Y
- KMID: 2557315
- Kidney Res Clin Pract.
- 2024 May;43(3):326-336.
- doi: 10.23876/j.krcp.23.121
Background: We assessed the anti-SARS-CoV-2 spike antibody response to the third dose of BNT162b2 mRNA COVID-19 vaccine in Japanese hemodialysis patients and determined factors associated with the anti-SARS-CoV-2 spike antibody... -
- CITED
-
- Close
- SHARE
-
- Close
- Relationship between serum total carbon dioxide concentration and bicarbonate concentration in patients undergoing hemodialysis
-
Hirai K, Ookawara S, Morino J, Minato S, Kaneko S, Yanai K, Ishii H, Matsuyama M, Kitano T, Shindo M, Miyazawa H, Ito K, Ueda Y, Watano T, Fujino S, Omoto K, Morishita Y
- KMID: 2509805
- Kidney Res Clin Pract.
- 2020 Dec;39(4):441-450.
- doi: 10.23876/j.krcp.19.126
Background: Few studies have investigated the relationship between serum total carbon dioxide (CO2) concentration and bicarbonate ion (HCO3-) concentration in patients undergoing hemodialysis. We determined the agreement and discrepancy between... -
- CITED
-
- Close
- SHARE
-
- Close
- Intestinal ultrasound for intestinal Behçet disease reflects endoscopic activity and histopathological findings
-
Yaguchi K, Kunisaki R, Sato S, Hirai K, Izumi M, Fukuno Y, Tanaka M, Okazaki M, Wu R, Nishikawa Y, Matsune Y, Shibui S, Nakamori Y, Nishio M, Matsubayashi M, Ogashiwa T, Fujii A, Toritani K, Kimura H, Kumagai E, Sasahara Y, Inayama Y, Fujii S, Ebina T, Numata K, Maeda S
- KMID: 2558190
- Intest Res.
- 2024 Jul;22(3):297-309.
- doi: 10.5217/ir.2023.00129
Background/Aims: Intestinal Behçet disease is typically associated with ileocecal punched-out ulcers and significant morbidity and mortality. Intestinal ultrasound is a noninvasive imaging technique for disease monitoring. However, no previous reports... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficacy and safety of adding mizoribine to standard treatment in patients with immunoglobulin A nephropathy: A randomized controlled trial
-
Hirai K, Ookawara S, Kitano T, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hoshino T, Mori H, Yoshida I, Kubota K, Yamaji Y, Takeda T, Nakamura Y, Tabei K, Morishita
- KMID: 2384618
- Kidney Res Clin Pract.
- 2017 Jun;36(2):159-166.
- doi: 10.23876/j.krcp.2017.36.2.159
BACKGROUND: Mizoribine (MZR) is an immunosuppressive drug used in Japan for treating patients with lupus nephritis and nephrotic syndrome and has been also reportedly effective in patients with immunoglobulin A... -
- CITED
-
- Close
- SHARE
-
- Close
- Approximation of bicarbonate concentration using serum total carbon dioxide concentration in patients with non-dialysis chronic kidney disease
-
Hirai K, Minato S, Kaneko S, Yanai K, Ishii H, Kitano T, Shindo M, Miyazawa H, Ito K, Ueda Y, Kaku Y, Hoshino T, Watano T, Fujino S, Ookawara S, Omoto K, Morishita
- KMID: 2457724
- Kidney Res Clin Pract.
- 2019 Sep;38(3):326-335.
- doi: 10.23876/j.krcp.19.027
BACKGROUND: We investigated the relationship between serum total carbon dioxide (COâ‚‚) and bicarbonate ion (HCO₃â») concentrations in pre-dialysis chronic kidney disease (CKD) patients and devised a formula for predicting low... -
- CITED
-
- Close
- SHARE
-
- Close
